X-Mozilla-Keys:
Date: Fri, 30 Aug 2013 16:44:43 GMT
Message-Id: <http://www.reuters.com/article/2013/08/30/us-teva-study-depression-idUSBRE97T0OJ20130830?feedType=RSS&feedName=healthNews@localhost.localdomain>
From: <Reuters: Health News>
MIME-Version: 1.0
Subject: Teva to drop depression treatment after trial fails
Content-Transfer-Encoding: 8bit
Content-Base: http://feeds.reuters.com/~r/reuters/healthNews/~3/XSEmD8TqTKk/story01.htm
Content-Type: text/html; charset=UTF-8
<html>
<head>
<title>Teva to drop depression treatment after trial fails</title>
<base href="http://feeds.reuters.com/~r/reuters/healthNews/~3/XSEmD8TqTKk/story01.htm">
</head>
<body id="msgFeedSummaryBody" selected="false">
(Reuters) - Generic drugmaker Teva Pharmaceutical Industries Ltd said it will stop development of a depression treatment after a late-stage trial failed to show the drug was more effective than placebo.<img width='1' height='1' src='http://reuters.us.feedsportal.com/c/35217/f/654207/s/309a14e0/sc/11/mf.gif' border='0'/><br clear='all'/><br/><br/><a href="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/1/rc.htm"><img src="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/1/rc.img" border="0"/></a><br/><a href="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/2/rc.htm"><img src="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/2/rc.img" border="0"/></a><br/><a href="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/3/rc.htm"><img src="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/sc/11/rc/3/rc.img" border="0"/></a><br/><br/><a href="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/a2.htm"><img src="http://da.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/a2.img" border="0"/></a><img width="1" height="1" src="http://pi.feedsportal.com/r/174726392504/u/49/f/654207/c/35217/s/309a14e0/a2t.img" border="0"/><div class="feedflare">
<a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=XSEmD8TqTKk:SMTmiLhuhlE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=XSEmD8TqTKk:SMTmiLhuhlE:F7zBnMyn0Lo"><img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=XSEmD8TqTKk:SMTmiLhuhlE:F7zBnMyn0Lo" border="0"></img></a> <a href="http://feeds.reuters.com/~ff/reuters/healthNews?a=XSEmD8TqTKk:SMTmiLhuhlE:V_sGLiPBpWU"><img src="http://feeds.feedburner.com/~ff/reuters/healthNews?i=XSEmD8TqTKk:SMTmiLhuhlE:V_sGLiPBpWU" border="0"></img></a>
</div><img src="http://feeds.feedburner.com/~r/reuters/healthNews/~4/XSEmD8TqTKk" height="1" width="1"/>
</body>
</html>
No comments:
Post a Comment